Skip to main content

Table 4 Univariate and multivariate analysis of the risk factors of moderate to severe post-ERCP pancreatitis

From: The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis

 

Moderate to severe PEP

Univariate

Multivariate

OR (95% CI)

P

OR (95% CI)

P

Age < 50

3.10 (0.72–11.53)

0.098

3.60 (1.09–11.85)

0.035

Female

3.52 (0.77–16.11)

0.104

  

P-duct manipulation

1.11 (0.35–3.51)

0.858

  

Precut biliary EST

1.24 (0.39–3.91)

0.717

  

Pancreatic EST

0.30 (0.04–2.34)

0.251

  

ERPD

1.76 (0.52–5.92)

0.363

1.61 (0.46–5.59)

0.457

Nafamostat mesilate

0.32 (0.10–1.00)

0.051

0.30 (0.09–0.98)

0.047

  1. Multivariate analysis included variables with P-value < 0.1 in univariate analysis
  2. PEP post-ERCP pancreatitis, OR odds ratio, CI confidence interval, P-duct pancreatic duct, EST endoscopic sphincterotomy, EPBD endoscopic papillary balloon dilatation, ERPD endoscopic retrograde pancreatic drainage